First Time Loading...

InflaRx NV
NASDAQ:IFRX

Watchlist Manager
InflaRx NV Logo
InflaRx NV
NASDAQ:IFRX
Watchlist
Price: 1.29 USD -0.39% Market Closed
Updated: May 7, 2024

InflaRx NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InflaRx NV
Revenue Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
InflaRx NV
NASDAQ:IFRX
Revenue
€63.1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Revenue
€3.8B
CAGR 3-Years
99%
CAGR 5-Years
97%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Revenue
€238.3m
CAGR 3-Years
-10%
CAGR 5-Years
26%
CAGR 10-Years
12%
Immatics NV
NASDAQ:IMTX
Revenue
€54m
CAGR 3-Years
20%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Revenue
€684.6m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
3%
Formycon AG
XETRA:FYB
Revenue
€42.5m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is InflaRx NV's Revenue?
Revenue
63.1k EUR

Based on the financial report for Dec 31, 2023, InflaRx NV's Revenue amounts to 63.1k EUR.